Author:
Warren George,Osborn Myles,Tsantoulas Christopher,David-Pereira Ana,Cohn Daniel,Duffy Paul,Ruston Linette,Johnson Clare,Bradshaw Heather,Kaczocha Martin,Ojima Iwao,Yates Andrew,O’Sullivan Saoirse E
Subject
Anesthesiology and Pain Medicine,Neurology (clinical),Neurology
Reference70 articles.
1. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis;Seretny;Pain,2014
2. Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer;Pike;Chemother Res Pract,2012
3. National Cancer Institute: Cancer Statistics: NIH; 2020 [updated 2020 September; cited 2023 November]. Accessed Nov 2023, https://www.cancer.gov/about-cancer/understanding/statistics.
4. Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment;Burgess;Oncol Ther,2021
5. The incidence of acute oxaliplatin-induced neuropathy and its impact on treatment in the first cycle: a systematic review;Gebremedhn;BMC Cancer,2018